Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / South Africa

Litha Signs Multiple Generic Drug Licenses As Part Of Local And Regional Expansion Plan

December 2011 | Industry Trend Analysis

BMI View: Litha Healthcare Group's strategy of rapid acquisitions to diversify its product sales in vaccines, pharmaceuticals and medical devices is well timed to take advantage of the strong growth expected in South Africa and across the region. With 98% of sales coming from the South African market and only 6% of sales generated from sales of pharmaceuticals, there is room for Litha to expand through licensing agreements for generic drugs that are unrelated to HIV/AIDS and malaria, where the market is already saturated with generic drugmakers. Its logistical operations division will be vital to become a significant regional

To read the full article, please choose one of the following options:

Subcribers please log in

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries